BBIO
BridgeBio Pharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website bridgebio.com
- Employees(FY) 392
- ISIN US10806X1028
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: BBIO
Overview
BBIO is a biotechnology company operating in the Health Technology sector. The company has shown significant growth in market capitalization over the years, indicating investor interest in its potential. In this report, we will analyze BBIO's financial health, earnings and revenue growth, profitability, ...
Technical Analysis of BBIO 2024-05-10
Overview:
In analyzing the technical indicators for BBIO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-24 07:30
- 2024-05-23 19:30
- 2024-05-22 06:37
- 2024-05-15 07:30
- 2024-05-14 19:30
- 2024-05-14 07:30
- 2024-05-13 19:30
- 2024-05-13 07:30
- 2024-05-12 19:30
- 2024-05-04 09:26
- 2024-05-03 06:44
BridgeBio Pharma First Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-05-03 06:22
BridgeBio Oncology Therapeutics launches with $200m funding(Pharmaceutical Technology)
- 2024-05-02 10:55
- 2024-05-02 10:27
- 2024-05-02 07:40
BridgeBio Pharma: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-02 07:30
- 2024-05-02 07:00
- 2024-05-02 03:00
BridgeBio spinout launches with $200M for KRAS cancer drugs(BioPharma Dive)
- 2024-05-01 19:30
- 2024-05-01 19:00
- 2024-05-01 08:10
- 2024-04-25 10:02
- 2024-04-24 22:02
- 2024-04-10 07:30
- 2024-04-09 19:30
- 2024-04-07 13:15
- 2024-04-07 01:15
- 2024-03-27 09:25
- 2024-03-20 07:30
- 2024-03-19 19:30